688 related articles for article (PubMed ID: 17483367)
1. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
Sinha P; Clements VK; Fulton AM; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4507-13. PubMed ID: 17483367
[TBL] [Abstract][Full Text] [Related]
2. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X
J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159
[TBL] [Abstract][Full Text] [Related]
3. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
4. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
Sinha P; Clements VK; Ostrand-Rosenberg S
Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
[TBL] [Abstract][Full Text] [Related]
7. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
Sinha P; Okoro C; Foell D; Freeze HH; Ostrand-Rosenberg S; Srikrishna G
J Immunol; 2008 Oct; 181(7):4666-75. PubMed ID: 18802069
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
Ansari KM; Sung YM; He G; Fischer SM
Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
[TBL] [Abstract][Full Text] [Related]
12. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
Bunt SK; Yang L; Sinha P; Clements VK; Leips J; Ostrand-Rosenberg S
Cancer Res; 2007 Oct; 67(20):10019-26. PubMed ID: 17942936
[TBL] [Abstract][Full Text] [Related]
13. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.
Ochoa AC; Zea AH; Hernandez C; Rodriguez PC
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):721s-726s. PubMed ID: 17255300
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells.
Nefedova Y; Fishman M; Sherman S; Wang X; Beg AA; Gabrilovich DI
Cancer Res; 2007 Nov; 67(22):11021-8. PubMed ID: 18006848
[TBL] [Abstract][Full Text] [Related]
15. Myeloid suppressor cells regulate the lung environment--letter.
Bosiljcic M; Hamilton MJ; Banath JP; Lepard NE; McDougal DC; Jia JX; Krystal G; Bennewith KL
Cancer Res; 2011 Jul; 71(14):5050-1; author reply 5052-3. PubMed ID: 21750177
[TBL] [Abstract][Full Text] [Related]
16. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
[TBL] [Abstract][Full Text] [Related]
17. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
18. A role for immature myeloid cells in immune senescence.
Enioutina EY; Bareyan D; Daynes RA
J Immunol; 2011 Jan; 186(2):697-707. PubMed ID: 21148798
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of an IL-1alpha vaccine depends on IL-1RI availability and concomitant myeloid-derived suppressor cell reduction.
Weiss T; Vitacolonna M; Zöller M
J Immunother; 2009; 32(6):552-64. PubMed ID: 19483654
[TBL] [Abstract][Full Text] [Related]
20. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
